Header Logo

Connection

GAGAN SOOD to Risk Assessment

Back to Details
This is a "connection" page, showing publications GAGAN SOOD has written about Risk Assessment.
GAGAN SOOD
Connection Strength
0.085
Risk Assessment
  1. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2010 May; 25(5):880-5.
    View in: PubMed
    Score: 0.043
  2. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol. 2010 Feb; 8(2):192-9.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.